Navigation Links
Trillium expands immunology pipeline and enters stem cell field through in-licensing of two new programs
Date:3/11/2010

utics Inc. is a private biopharmaceutical company specializing in innovative therapies of immune-mediated conditions, such as autoimmune and inflammatory disorders, as well as cancer. The company's lead program, TTI-1612, is a recombinant growth factor that is being developed for the treatment of interstitial cystitis (IC) and the prevention of necrotizing enterocolitis (NEC). Trillium has broad portfolio preclinical immunology programs, including two partnered programs that target the CD200 immunoregulatory axis; a CD200-specific monoclonal antibody for the treatment of cancer, and a CD200Fc fusion protein for the treatment of autoimmune and inflammatory diseases. In addition, the company has an FcgRIIa-specific humanized monoclonal antibody in development for treatment of immune complex-mediated inflammatory diseases.

The company has a broad network of external academic and industry R&D collaborations, including several license agreements with major US biotechnology companies. The Company is supported by three premier venture capital investors: Vengrowth Private Equity Partners, Growthworks Capital and BDC Capital.

SOURCE Trillium Therapeutics Inc.

Back to top
'/>"/>
SOURCE Trillium Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Trillium adds industry veteran Dr. Mike Gresser to its Board of Directors
2. Trillium and Biogen Idec enter into global license agreement
3. Trillium Strengthens its Board of Directors
4. Trillium secures additional financing on the strength of lead program and proprietary position around the CD200 immunoregulatory pathway
5. Epeius Biotechnologies Corporation Expands its Rexin-G Production Facilities in Southern California
6. BioMed Realty Trust Expands Lease With Ironwood Pharmaceuticals for 50,000 Square Feet in Cambridge, Massachusetts
7. Laboratory Products Leader Sterlitech Expands RO Membranes Line
8. Glycos Biotechnologies Expands Management Team with Appointment of Vice President of Research and Development
9. Progenitor Cell Therapy Expands Manufacturing Operations
10. Karolinska Development Expands its Life Science Portfolio With BioChromix Pharma
11. Wound Management Technologies, Inc. Rapidly Expands Its International Presence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015  RXi Pharmaceuticals ... focused on discovering and developing innovative therapies primarily ... an update on the status of the Company,s ... Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO ... 3,085 and 21 shares of Series A Preferred ...
(Date:5/26/2015)... WORMS, GERMANY – May 26, 2015 ... announces that its manufacturing facility in Worms, Germany ... EXCiPACTâ„¢, an independent organization that certifies manufacturers, suppliers, ... All three Grace facilities that produce its SYLOID® ... have now received GMP certification, following the Curtis ...
(Date:5/26/2015)... 26, 2015   Intrexon Corporation (NYSE: XON ... Gregory Frost , Ph.D., Senior Vice President and Head of ... Healthcare Conference on Wednesday, June 3 rd , at 1:30 ... New York City . About Intrexon Corporation ... the Bioindustrial Revolution with Better DNA ™ to create ...
(Date:5/26/2015)... 26, 2015   PDI , a leader ... that Oakwood Healthcare in Dearborn, Mich. ... entry in Delivering the Difference ... excellence in building collaborative relationships between infection prevention ... facilities.  Oakwood Healthcare,s infection preventionist, ...
Breaking Biology Technology:RXi Pharmaceuticals Provides an Update on Series A and Series A-1 Preferred Stock 2RXi Pharmaceuticals Provides an Update on Series A and Series A-1 Preferred Stock 3CORRECTION: Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2Intrexon to Present at the Jefferies 2015 Global Healthcare Conference 2PDI Announces Winner in Delivering the Difference Contest 2PDI Announces Winner in Delivering the Difference Contest 3
... N.J., April 15 Quest Diagnostics,Incorporated (NYSE: ... of the,previously disclosed federal government investigation related to ... manufacturing subsidiary closed,voluntarily in 2006. Quest Diagnostics cooperated ... , Quest Diagnostics will ...
... announced today that it,has completed the formation of ... existing group of Senior Advisers. NexBio recently ... investigational drug,candidate for influenza. The new CAB will ... medicine, helping the company to conduct advanced,product development ...
... BELGIUM, Wis., April 15 Mach One Corporation ... company, announces Monte B. Tobin, the President and ... One,s shareholders:Dear Fellow Shareholders:The mission of Mach One ... global wellness organizations that provide bio-based solutions to ...
Cached Biology Technology:Quest Diagnostics Finalizes Previously Announced Settlement With Government Related to Test Kit Subsidiary Closed in 2006 2NexBio Completes Clinical Advisory Board for the Advanced Development of DAS181 (Fludase(R)*), a First-In-Class Medicine for Influenza 2NexBio Completes Clinical Advisory Board for the Advanced Development of DAS181 (Fludase(R)*), a First-In-Class Medicine for Influenza 3NexBio Completes Clinical Advisory Board for the Advanced Development of DAS181 (Fludase(R)*), a First-In-Class Medicine for Influenza 4Mach One CEO Letter to Shareholders 2Mach One CEO Letter to Shareholders 3Mach One CEO Letter to Shareholders 4
(Date:4/20/2015)... The announcement comes as demand for fire ... Ireland,s foremost records management company, has ... an impressive track record of clients within the first 12 ... management sector in Dubai . As a ... employ a further eight staff members at its Irish headquarters. ...
(Date:4/14/2015)... 14, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market, announces that ... 2015 New York Design Awards under the category  ,Product ... City Design Awards are part of a global multi-disciplinary ... ratings from the marketplace, industry and judging panel. Winners ...
(Date:4/10/2015)... April 10, 2015 Research and ... the "Security Competitive Profiles - NEC" report ... NEC will continue to supply a range ... market, with a company focus on the development of ... Winning opportunities in the Asia-Pacific ...
Breaking Biology News(10 mins):Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3NEC Security Competitive Profile 2015 2
... are those that occur outside their natural range and ... can be plants, animals or microorganisms that are introduced ... tourism, travel or trade, or when domestic animals become ... the rising cost of invasive species on a global ...
... were once credited with magical healing powers but are now ... but the cause of numerous diseases such as diabetes if ... the vital role played by more complex sugars in many ... This all emerged in a recent workshop organised by ...
... (Jan. 16, 2008) -- Two major federal grants have been ... in New York City. Dr. Kenneth W. Griffin ... from the National Institute on Drug Abuse (NIDA) for research ... previously delivered to urban minority youth attending New York City ...
Cached Biology News:Scientists call for urgent research into 'real' impacts of invasive species 2Scientists call for urgent research into 'real' impacts of invasive species 3ESF's workshop restores good name of sugar 2ESF's workshop restores good name of sugar 32 federal public health grants awarded to Weill Cornell Medical College 2
Buckets for tube holder inserts...
... spotting and preparation for MS analysis. ... can be accurately and continuously spotted onto ... solutions can be added automatically. This allows ... MALDI-TOF-MS measurements. By using it in conjunction ...
A camera based compact unit for high speed scanning of 2D barcoded tubes in a cluster rack. This reader has been designed to read both 96 and 48 tube rack configurations and be compatible with common...
A compact, high-speed single tube reader unit designed for benchtop 2D barcode reading. The unit can be used with all of ABgene's 2D barcoded tubes, including the 2ml CryoCode tube....
Biology Products: